551
Views
85
CrossRef citations to date
0
Altmetric
Gastrointestinal cancer

Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany

, , , , , , , & show all
Pages 1092-1098 | Received 23 Mar 2011, Accepted 28 Apr 2011, Published online: 22 Jun 2011

References

  • Anderson RN, Arias E. The effect of revised populations on mortality statistics for the United States, 2000. Natl Vital Stat Rep 2003;51:1–24.
  • Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010;42(Suppl 3):S206–14.
  • Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008;14:4300–8.
  • Sherman M. Epidemiology of hepatocellular carcinoma. Oncology 2010;78(Suppl 1):7–10.
  • Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002;51(Suppl 6):VI1–9.
  • Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24:115–25.
  • Sherman M, Takayama Y. Screening and treatment for hepatocellular carcinoma. Gastroenterol Clin North Am 2004;33:671–91, xi.
  • Cardinale V, Semeraro R, Torrice A, Gatto M, Napoli C, Bragazzi MC, Intra-hepatic and extra-hepatic cholangiocarcinoma: new insight into epidemiology and risk factors. World J Gastrointestin Oncol 2010;2:407–16.
  • Libbrecht L. Hepatic progenitor cells in human liver tumor development. World J Gastroenterol 2006;12:6261–5.
  • Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang Y, Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma - focus on east and south-eastern Asia. Asian Pac J Cancer Prev 2010;11:1159–66.
  • Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001;48:816–20.
  • McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006;15:1198–203.
  • Alvaro D, Bragazzi MC, Benedetti A, Fabris L, Fava G, Invernizzi P, Cholangiocarcinoma in Italy: a national survey on clinical characteristics, diagnostic modalities and treatment. Results from the “Cholangiocarcinoma” committee of the Italian Association for the Study of Liver disease. Dig Liver Dis 2010;43:60–5.
  • Singal AK, Vauthey JN, Grady JJ, Stroehlein JR. Intra-hepatic cholangiocarcinoma-frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center. J Cancer Res Clin Oncol 2011.
  • Lepage C, Cottet V, Chauvenet M, Phelip JM, Bedenne L, Faivre J, Trends in the incidence and management of biliary tract cancer: a French population-based study. J Hepatol 2010;54:306–10.
  • Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006;98:873–5.
  • Erichsen R, Jepsen P, Vilstrup H, Ekbom A, Sorensen HT. Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978-2003. Eur J Epidemiol 2009;24:513–20.
  • Jepsen P, Vilstrup H, Tarone RE, Friis S, Sorensen HT. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002. J Natl Cancer Inst 2007;99(11):895–7.
  • Hammill CW, Wong LL. Intrahepatic cholangiocarcinoma: a malignancy of increasing importance. J Am Coll Surg 2008;207:594–603.
  • Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002;2:10.
  • West J, Wood H, Logan RF, Quinn M, Aithal GP. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 2006;94:1751–8.
  • Alvaro D, Crocetti E, Ferretti S, Bragazzi MC, Capocaccia R. Descriptive epidemiology of cholangiocarcinoma in Italy. Dig Liver Dis 2010;42:490–5.
  • Duschek K, Julia W, Böhm K, Laue E, Brücker G. Leben in Deutschland – Haushalte, Familien und Gesundheit,Ergebnisse des Mikrozensus 2005: Statistisches Bundesamt – Pressestelle, Wiesbaden; 2006.
  • Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 2010;101:579–85.
  • El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 2009;49:116–23.
  • Koo SH, Ihm CH, Kwon KC, Park JW, Kim JM, Kong G. Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Genet Cytogenet 2001;130:22–8.
  • Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006;25:3818–22.
  • Gatto M, Alvaro D. New insights on cholangiocarcinoma. World J Gastrointest Oncol 2010;2:136–45.
  • Omenetti A, Bass LM, Anders RA, Clemente MG, Francis H, Guy CD, Hedgehog activity, epithelial-mesenchymal transitions, and biliary dysmorphogenesis in biliary atresia. Hepatology 2011;53:1246–58.
  • Jung Y, McCall SJ, Li YX, Diehl AM. Bile ductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis. Hepatology 2007;45:1091–6.
  • Ishimura N, Bronk SF, Gores GJ. Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis. Gastroenterology 2005;128:1354–68.
  • Zong Y, Panikkar A, Xu J, Antoniou A, Raynaud P, Lemaigre F, Notch signaling controls liver development by regulating biliary differentiation. Development 2009;136:1727–39.
  • Raynaud P, Tate J, Callens C, Cordi S, Vandersmissen P, Carpentier R, A classification of ductal plate malformations based on distinct pathogenic mechanisms of biliary dysmorphogenesis. Hepatology 2011;53(6):1959–66.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.